Exscientia
Oxford
About Exscientia
Exscientia combines human expertise with AI and machine learning to enhance drug discovery. The company focuses on precision engineering of medicine candidates, enabling faster and more efficient development of new treatments. By integrating innovative experimental techniques, Exscientia aims to improve patient outcomes and revolutionize the pharmaceutical industry.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $376.7M
- Funding stage: M&A
- Last round: Grant (Dec 2023)
- Ticker: nasdaq:EXAI
- Website: exscientia.ai
- Phone: +44-1865-818941
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/exscientia-269 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.